摘要
视网膜缺血再灌注损伤(retinal ischemia-reperfusion injury,RIRI)是一种在临床上极其常见的疾病,其发病机制还在研究中,近年实验及临床研究发现RIRI的机制大多与氧自由基、基因调控、钙超载、炎症因子等因素密切相关。我们对近些年国内外学者对中药提取成分防治RIRI的研究进展进行综述。
Retinal ischemia - reperfusion injury （ RlRl ） is a common clinical disease, and the producing mechanism is still in research. Experimental and clinical research in recent years have showed that the mechanism of RlRl and oxygen free radicals, gene regulation, calcium overload, inflammatory cytokines and other factors are closely related. ln this article, we summarized the current situation that the scholars at home and abroad study traditional Chinese medicine extract of prevention and treatment of RlRl.
出处
《国际眼科杂志》
CAS
2015年第5期810-812,共3页
International Eye Science
关键词
视网膜缺血再灌注损伤
中药提取成分
retinal ischemia - reperfusion injury
traditional Chinese medicine extract
